{"title":"巨淋巴结增生症临床分析","authors":"B. Jin, Xinghui Yang, Meijian Liao, Wei-na Bo","doi":"10.3760/CMA.J.ISSN.1673-4904.2000.11.007","DOIUrl":null,"url":null,"abstract":"Objective: To review the diagnosis and treatment of giant lymph node hyperplasia (GLNH). Method:Two cases of GLNH confirmed by surgery and pathology were presented and relevant literatures were reviewed, its aetiology, clinical presentation, pathology, diagnosis, differential diagnosis, treatment and prognosis were reviewed. Result: GLNH is a heterogeneous, uncommon lymphoproliferative benign disorder. GLNH is classified into hyaline-vascular (HV) and plasma-cell (PC) subtypes by histomorphologic criteria. The HV GLNH is commonly mediastinal lesion. The PC GLNH often involves mesenteric and retroperitoneal lymph nodes. Conclusion: GLNH is rare. The aetiology is unknown, most patients were asymptomatic, surgical resection is the first choice, the prognosis is good.","PeriodicalId":10229,"journal":{"name":"中国医师进修杂志","volume":"66 3-4 1","pages":"16-17"},"PeriodicalIF":0.0000,"publicationDate":"2000-11-15","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"GIANT LYMPH NODE HYPERPLASIA CLINICAL ANALYSIS\",\"authors\":\"B. Jin, Xinghui Yang, Meijian Liao, Wei-na Bo\",\"doi\":\"10.3760/CMA.J.ISSN.1673-4904.2000.11.007\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"Objective: To review the diagnosis and treatment of giant lymph node hyperplasia (GLNH). Method:Two cases of GLNH confirmed by surgery and pathology were presented and relevant literatures were reviewed, its aetiology, clinical presentation, pathology, diagnosis, differential diagnosis, treatment and prognosis were reviewed. Result: GLNH is a heterogeneous, uncommon lymphoproliferative benign disorder. GLNH is classified into hyaline-vascular (HV) and plasma-cell (PC) subtypes by histomorphologic criteria. The HV GLNH is commonly mediastinal lesion. The PC GLNH often involves mesenteric and retroperitoneal lymph nodes. Conclusion: GLNH is rare. The aetiology is unknown, most patients were asymptomatic, surgical resection is the first choice, the prognosis is good.\",\"PeriodicalId\":10229,\"journal\":{\"name\":\"中国医师进修杂志\",\"volume\":\"66 3-4 1\",\"pages\":\"16-17\"},\"PeriodicalIF\":0.0000,\"publicationDate\":\"2000-11-15\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"中国医师进修杂志\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.3760/CMA.J.ISSN.1673-4904.2000.11.007\",\"RegionNum\":0,\"RegionCategory\":null,\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"\",\"JCRName\":\"\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"中国医师进修杂志","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.3760/CMA.J.ISSN.1673-4904.2000.11.007","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
Objective: To review the diagnosis and treatment of giant lymph node hyperplasia (GLNH). Method:Two cases of GLNH confirmed by surgery and pathology were presented and relevant literatures were reviewed, its aetiology, clinical presentation, pathology, diagnosis, differential diagnosis, treatment and prognosis were reviewed. Result: GLNH is a heterogeneous, uncommon lymphoproliferative benign disorder. GLNH is classified into hyaline-vascular (HV) and plasma-cell (PC) subtypes by histomorphologic criteria. The HV GLNH is commonly mediastinal lesion. The PC GLNH often involves mesenteric and retroperitoneal lymph nodes. Conclusion: GLNH is rare. The aetiology is unknown, most patients were asymptomatic, surgical resection is the first choice, the prognosis is good.
期刊介绍:
Chinese Journal of Postgraduates of Medicine (founded in 1978, monthly) is one of the series of journals of the Chinese Medical Association (CMA) under the supervision of the National Health Commission of the People's Republic of China, sponsored by the Chinese Medical Association (CMA) and Dalian Institute of Theoretical Medicine (DITM). It is a core journal of Chinese science and technology, a statistical source journal of Chinese scientific and technical papers, and a statistical source journal of China Academic Journal Impact Factor Annual Report. The journal adheres to the purpose of using continuing medical education and post training, highlights new theories, new knowledge, new methods and new technologies, and focuses on the combination of theory and practice, and the combination of popularisation and improvement.
Main columns: Special tutorials, expert forums, clinical treatises, clinical experience, reviews and lectures, continuing medical education, teaching and research, advanced training forum, drugs and clinics, overview of progress, introduction of new technologies, imaging and clinics, lessons learnt, discussions and evaluations, case reports, discussions of clinical cases, conference proceedings, and domestic and international academic developments.
The main target readers are clinical medical personnel in internal medicine, surgery, gynaecology, paediatrics and ophthalmology.